Validation of a strategy to diagnose coronary artery disease and predict cardiac events in high-risk renal transplant candidates


Autoria(s): LIMA, Jose Jayme Galvao De; GOWDAK, Luis Henrique Wolff; PAULA, Flavio Jota de; IANHEZ, Luis Estevan; RAMIRES, Jose Antonio Franchini; KRIEGER, Eduardo M.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Background We validated a strategy for diagnosis of coronary artery disease ( CAD) and prediction of cardiac events in high-risk renal transplant candidates ( at least one of the following: age >= 50 years, diabetes, cardiovascular disease). Methods A diagnosis and risk assessment strategy was used in 228 renal transplant candidates to validate an algorithm. Patients underwent dipyridamole myocardial stress testing and coronary angiography and were followed up until death, renal transplantation, or cardiac events. Results The prevalence of CAD was 47%. Stress testing did not detect significant CAD in 1/3 of patients. The sensitivity, specificity, and positive and negative predictive values of the stress test for detecting CAD were 70, 74, 69, and 71%, respectively. CAD, defined by angiography, was associated with increased probability of cardiac events [log-rank: 0.001; hazard ratio: 1.90, 95% confidence interval (CI): 1.29-2.92]. Diabetes (P=0.03; hazard ratio: 1.58, 95% CI: 1.06-2.45) and angiographically defined CAD (P=0.03; hazard ratio: 1.69, 95% CI: 1.08-2.78) were the independent predictors of events. Conclusion The results validate our observations in a smaller number of high-risk transplant candidates and indicate that stress testing is not appropriate for the diagnosis of CAD or prediction of cardiac events in this group of patients. Coronary angiography was correlated with events but, because less than 50% of patients had significant disease, it seems premature to recommend the test to all high-risk renal transplant candidates. The results suggest that angiography is necessary in many high-risk renal transplant candidates and that better noninvasive methods are still lacking to identify with precision patients who will benefit from invasive procedures. Coron Artery Dis 21: 164-167 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Fundacao Zerbini, Sao Paulo, Brazil

Identificador

CORONARY ARTERY DISEASE, v.21, n.3, p.164-167, 2010

0954-6928

http://producao.usp.br/handle/BDPI/21796

10.1097/MCA.0b013e328332ee5e

http://dx.doi.org/10.1097/MCA.0b013e328332ee5e

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

Relação

Coronary Artery Disease

Direitos

restrictedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #coronary angiography #coronary artery disease #myocardial scan #KIDNEY-PANCREAS TRANSPLANTATION #PROGNOSTIC VALUE #MYOCARDIAL-PERFUSION #CARDIOVASCULAR EVENTS #HEMODIALYSIS #THERAPY #SPECT #Peripheral Vascular Disease
Tipo

article

original article

publishedVersion